And that delay - whatever its cause, if delay there was - allowed the FDA to approve two horrible AD competitor drugs. Against all recommendations. That was real plus for us and more than compensates for any "delays". I think many now see those approvals as "changing the landscape". Meaning the new landscape must have AD drugs that are not torture to the body to administer and subsequently "live with"!....And that show real obvious benefit, not b.s. benefit. That was kind of thing people thought they were supposed to get after swallowing all the fake hype that accompanied those approvals. Then they read the fine print.....
"We was hoodwinked!....Bamboozled*! !"
*(a popular word these days, I've noticed)
News 
Market Data 
Discover 
